USANA Health Sciences (NYSE:USNA) Lowered to “Hold” Rating by Sidoti

USANA Health Sciences (NYSE:USNA) was downgraded by research analysts at Sidoti from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Several other analysts have also commented on the company. DA Davidson increased their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the company a “neutral” rating in a report on Thursday, January 2nd. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th.

USANA Health Sciences Stock Down 0.8 %

NYSE:USNA opened at $31.16 on Tuesday. The stock has a market capitalization of $593.99 million, a price-to-earnings ratio of 11.01, a PEG ratio of 0.85 and a beta of 0.87. USANA Health Sciences has a 52 week low of $30.13 and a 52 week high of $50.32. The firm has a 50 day moving average of $34.02 and a 200 day moving average of $36.85.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Creative Planning purchased a new stake in shares of USANA Health Sciences during the third quarter valued at $394,000. Allspring Global Investments Holdings LLC grew its stake in USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after purchasing an additional 38,547 shares during the last quarter. Assenagon Asset Management S.A. increased its holdings in shares of USANA Health Sciences by 13.5% in the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock valued at $4,702,000 after purchasing an additional 14,756 shares during the period. Harbor Capital Advisors Inc. raised its stake in shares of USANA Health Sciences by 44.1% in the third quarter. Harbor Capital Advisors Inc. now owns 8,859 shares of the company’s stock worth $336,000 after purchasing an additional 2,713 shares during the last quarter. Finally, KBC Group NV lifted its holdings in shares of USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after purchasing an additional 519 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.